Encompass Health Corporation $EHC Shares Acquired by MGO One Seven LLC

MGO One Seven LLC grew its stake in Encompass Health Corporation (NYSE:EHC) by 56.4% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 4,382 shares of the company’s stock after purchasing an additional 1,581 shares during the period. MGO One Seven LLC’s holdings in Encompass Health were worth $537,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. OneDigital Investment Advisors LLC acquired a new position in shares of Encompass Health in the first quarter valued at approximately $263,000. GAMMA Investing LLC grew its holdings in Encompass Health by 21.5% during the first quarter. GAMMA Investing LLC now owns 2,366 shares of the company’s stock worth $240,000 after acquiring an additional 419 shares during the period. Sequoia Financial Advisors LLC grew its holdings in Encompass Health by 6.7% during the first quarter. Sequoia Financial Advisors LLC now owns 2,727 shares of the company’s stock worth $276,000 after acquiring an additional 172 shares during the period. Cambridge Investment Research Advisors Inc. grew its holdings in Encompass Health by 30.1% during the first quarter. Cambridge Investment Research Advisors Inc. now owns 9,597 shares of the company’s stock worth $972,000 after acquiring an additional 2,218 shares during the period. Finally, Intech Investment Management LLC grew its holdings in Encompass Health by 21.8% during the first quarter. Intech Investment Management LLC now owns 21,329 shares of the company’s stock worth $2,160,000 after acquiring an additional 3,815 shares during the period. Institutional investors and hedge funds own 97.25% of the company’s stock.

Encompass Health Stock Up 1.3%

Encompass Health stock opened at $124.55 on Friday. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.06 and a current ratio of 1.06. The firm has a market capitalization of $12.55 billion, a price-to-earnings ratio of 24.37, a price-to-earnings-growth ratio of 2.15 and a beta of 0.93. Encompass Health Corporation has a fifty-two week low of $87.85 and a fifty-two week high of $127.86. The stock’s fifty day moving average is $123.56 and its two-hundred day moving average is $117.15.

Encompass Health (NYSE:EHC) last posted its earnings results on Wednesday, March 16th. The company reported $0.93 earnings per share for the quarter. The company had revenue of $136.30 million for the quarter. Encompass Health had a return on equity of 17.83% and a net margin of 9.22%. Encompass Health has set its FY22 guidance at $3.83-$4.19 EPS. Analysts predict that Encompass Health Corporation will post 4.8 EPS for the current fiscal year.

Encompass Health Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st were issued a dividend of $0.19 per share. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.6%. This is a boost from Encompass Health’s previous quarterly dividend of $0.17. The ex-dividend date was Wednesday, October 1st. Encompass Health’s payout ratio is presently 14.87%.

Analyst Ratings Changes

A number of research analysts recently weighed in on the company. Truist Financial upped their price objective on Encompass Health from $135.00 to $140.00 and gave the stock a “buy” rating in a report on Thursday, August 14th. UBS Group upped their price objective on Encompass Health from $140.00 to $150.00 and gave the stock a “buy” rating in a report on Thursday, October 2nd. Bank of America upped their price objective on Encompass Health from $145.00 to $160.00 and gave the stock a “buy” rating in a report on Wednesday, September 10th. KeyCorp upped their price objective on Encompass Health from $135.00 to $140.00 and gave the stock an “overweight” rating in a report on Tuesday, September 16th. Finally, Weiss Ratings reissued a “buy (b+)” rating on shares of Encompass Health in a report on Wednesday, October 8th. One research analyst has rated the stock with a Strong Buy rating and eight have issued a Buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Buy” and a consensus target price of $139.86.

Insider Buying and Selling at Encompass Health

In other news, EVP Patrick William Tuer sold 1,020 shares of the business’s stock in a transaction that occurred on Wednesday, August 27th. The shares were sold at an average price of $123.59, for a total value of $126,061.80. Following the completion of the transaction, the executive vice president owned 18,846 shares of the company’s stock, valued at $2,329,177.14. The trade was a 5.13% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 2.00% of the stock is currently owned by corporate insiders.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.